As alopecia or hair loss is the most common side-effect associated with the treatment of most solid tumors, management of chemotherapy induced side-effects is a major challenge. In 2015, FDA approved the use of scalp cooling system for patients with stage 1 breast cancer. Now, FDA has approved its use for patients with a solid tumor. This article describes the expanded use of scalp cooling system. A scalp cooling system is designed to reduce the frequency and severity of alopecia during chemotherapy in solid tumor cancer patients.
It is a computer-controlled system used during treatment. A cap is worn on the head and circulates liquid to a cap to cool the scalp during chemotherapy treatment. Mechanism of SCS Cooling caused by SCS causes constriction of blood vessels in the scalp which further reduces the amount of chemotherapeutic drugs that reaches in the hair follicle cells. The cold…
